PHYSIOLOGICAL EFFECTS OF DRUGS
Clinical trials for PHYSIOLOGICAL EFFECTS OF DRUGS explained in plain language.
Never miss a new study
Get alerted when new PHYSIOLOGICAL EFFECTS OF DRUGS trials appear
Sign up with your email to follow new studies for PHYSIOLOGICAL EFFECTS OF DRUGS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study tests whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as two blood thinners (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 p…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 26, 2026 02:01 UTC
-
Could dimephosphon help stroke patients recover faster?
Disease control Recruiting nowThis study tests whether an investigational drug called Dimephosphon can improve recovery in people who have had an acute ischemic stroke (a stroke caused by a blood clot). The trial involves 184 adults aged 35-80 who receive either Dimephosphon or a placebo within 24-72 hours of…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Tatchempharmpreparaty, JSC • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Heart surgery brain fog: could a simple sedative be the answer?
Disease control Recruiting nowThis study tests whether a sedative called dexmedetomidine can prevent long-term memory and thinking problems that often occur after heart surgery. Researchers will enroll 2,400 adults aged 60 and older who are having bypass or valve surgery. Participants will receive either dexm…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE4 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
New drug aims to lift depression in days, not weeks
Symptom relief Recruiting nowThis study tests whether a new drug called (2R,6R)-HNK can quickly improve symptoms in adults with major depression that hasn't responded to other treatments. About 50 participants will receive four infusions of the drug and four of a placebo over several weeks, with their mood a…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated May 26, 2026 02:11 UTC
-
New injection aims to smooth neck bands in major trial
Symptom relief Recruiting nowThis study tests an injection called NT 201 (a type of botulinum toxin) against a placebo to see if it safely reduces the appearance of moderate to severe neck bands (platysma prominence) in adults. About 300 participants in Europe will receive either the treatment or a placebo, …
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC
-
NIH launches study to decode depression and suicide risk
Knowledge-focused Recruiting nowThis study follows 500 adults with depression, bipolar disorder, or suicide risk who are already receiving care. Researchers will use interviews, questionnaires, and optional tests like blood draws and brain scans to track how symptoms change over time. The goal is to find better…
Matched conditions: PHYSIOLOGICAL EFFECTS OF DRUGS
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated May 26, 2026 02:09 UTC